<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Evan Albright — Digest tagged &quot;psychiatry&quot;</title><description>Digest issues tagged #psychiatry.</description><link>https://www.evanalbright.com/</link><language>en-us</language><item><title>OpenAI&apos;s custom chip arrives as Anthropic accuses Alibaba of model extraction</title><link>https://www.evanalbright.com/digest/2026-06-25/</link><guid isPermaLink="true">https://www.evanalbright.com/digest/2026-06-25/</guid><description>Anthropic accused Alibaba of illicitly extracting Claude&apos;s model capabilities, drawing 829 Hacker News comments and raising fresh questions about AI IP enforcement. OpenAI unveiled Jalapeño, its first custom inference chip built with Broadcom, a move that reshapes its dependency on Nvidia. GLM-5.2 crossed a threshold Nathan Lambert called the step change for open agents. Google introduced computer use in Gemini 3.5 Flash, and U.S. health spending rose 7.3% in 2025, driven by GLP-1 drug adoption and higher care utilization. A bipartisan bill would expand methadone access by letting physicians prescribe it outside specialty clinics.</description><pubDate>Thu, 25 Jun 2026 00:00:00 GMT</pubDate><category>ai</category><category>pharma</category><category>economy</category><category>software</category><category>healthtech</category><category>open-weights</category><category>chip</category><category>glp-1</category><category>agents</category><category>benchmarks</category><category>legal</category><category>china</category><category>post-quantum</category><category>clinical-trials</category><category>labor</category><category>stablecoins</category><category>ev</category><category>industrial-policy</category><category>business-formation</category><category>methadone</category><category>ebola</category><category>cardiac</category><category>drug-discovery</category><category>prompt-injection</category><category>computer-use</category><category>inference</category><category>hardware</category><category>developer-tools</category><category>sustainability</category><category>claude</category><category>ip</category><category>anthropic</category><category>openai</category><category>broadcom</category><category>glm</category><category>chinese-models</category><category>llm</category><category>gemini</category><category>google</category><category>multimodal</category><category>qualcomm</category><category>m&amp;a</category><category>edge-ai</category><category>evals</category><category>leaderboards</category><category>methodology</category><category>security</category><category>safety</category><category>hiring</category><category>code-generation</category><category>authenticity</category><category>databricks</category><category>enterprise</category><category>strategy</category><category>data-centers</category><category>cooling</category><category>nvidia</category><category>infrastructure</category><category>retrieval</category><category>embeddings</category><category>language</category><category>reasoning</category><category>policy</category><category>regulation</category><category>geopolitics</category><category>finance</category><category>business</category><category>fable</category><category>cost</category><category>optimization</category><category>frameworks</category><category>tools</category><category>knowledge</category><category>training</category><category>fine-tuning</category><category>open-source</category><category>fraud</category><category>cryptography</category><category>software-engineering</category><category>management</category><category>oauth</category><category>auth</category><category>cloudflare</category><category>rust</category><category>http</category><category>debugging</category><category>sqlite</category><category>mcp</category><category>data</category><category>health-spending</category><category>cms</category><category>economics</category><category>infectious-disease</category><category>who</category><category>gilead</category><category>opioids</category><category>addiction</category><category>legislation</category><category>biotech</category><category>biosecurity</category><category>vaccines</category><category>bio-conference</category><category>mrna</category><category>transgender</category><category>doj</category><category>healthcare</category><category>lgbtq</category><category>privacy</category><category>market</category><category>down-syndrome</category><category>ethics</category><category>disability</category><category>treatment</category><category>confidentiality</category><category>psychiatry</category><category>hair-loss</category><category>spending</category><category>clinical-trial</category><category>fda</category><category>cardiology</category><category>prediction</category><category>ecg</category><category>sudden-cardiac-death</category><category>nature</category><category>investors</category><category>eli-lilly</category><category>investment</category><category>screening</category><category>preventive-medicine</category><category>mri</category><category>evidence</category><category>cost-benefit</category><category>entrepreneurship</category><category>dynamism</category><category>startups</category><category>wages</category><category>inequality</category><category>macro</category><category>federal-reserve</category><category>clean-energy</category><category>obesity</category><category>marriage</category><category>behavioral</category><category>nih</category><category>health-policy</category><category>crypto</category><category>financial-stability</category><category>risk</category><category>history</category><category>london</category><category>philosophy</category><category>housing</category><category>affordability</category><category>research</category><category>science</category><category>links</category><category>tech</category><category>grants</category><category>fellowships</category><category>innovation</category><category>culture</category><category>uk</category><category>politics</category><category>substack</category><category>wellbeing</category><category>aging</category><category>macroeconomics</category><category>tax-policy</category><category>wealth</category><category>nordic-countries</category></item><item><title>US suspends Fable 5 access for foreign nationals as export controls hit frontier AI</title><link>https://www.evanalbright.com/digest/2026-06-15/</link><guid isPermaLink="true">https://www.evanalbright.com/digest/2026-06-15/</guid><description>The US government issued an export control directive suspending all access to Claude Fable 5 and Mythos 5 for foreign nationals, a move that rattled the AI industry and prompted Tyler Cowen to note the equilibrium was hard to solve for. Separately, Arvind Narayanan and Sayash Kappoor published a detailed argument that software engineers won&apos;t be replaced by AI, citing task fragmentation and the compounding cost of errors. The FDA approved Sanofi&apos;s teplizumab for children with stage 3 type 1 diabetes after it cleared a dispute between career staff and political appointees. Noah Smith asked whether Chinese corporate debt could zombify the economy, while Patrick Boyle examined how SpaceX humiliated Wall Street by retaining founder control across 25x more fundraising than typical startups.</description><pubDate>Mon, 15 Jun 2026 00:00:00 GMT</pubDate><category>ai</category><category>software</category><category>pharma</category><category>healthtech</category><category>economy</category><category>claude</category><category>fable5</category><category>export-control</category><category>governance</category><category>policy</category><category>fda</category><category>drug-approval</category><category>spacex</category><category>ipo</category><category>china</category><category>prediction-markets</category><category>medicare</category><category>drug-shortage</category><category>llm</category><category>evals</category><category>agents</category><category>safety</category><category>syphilis</category><category>penicillin</category><category>medicaid</category><category>agi</category><category>software-engineering</category><category>jobs</category><category>economics</category><category>gdp</category><category>labor</category><category>macroeconomics</category><category>clinical</category><category>health-ai</category><category>benchmarks</category><category>education</category><category>training</category><category>nvidia</category><category>open-source</category><category>commoditization</category><category>analysis</category><category>trends</category><category>forecasting</category><category>rag</category><category>knowledge-graphs</category><category>reasoning</category><category>mlops</category><category>edge-ml</category><category>robotics</category><category>cnns</category><category>architecture</category><category>efficiency</category><category>cv</category><category>healthcare</category><category>applications</category><category>security</category><category>curl</category><category>engineering</category><category>apple</category><category>sdk</category><category>on-device</category><category>tools</category><category>provenance</category><category>formal-methods</category><category>programming</category><category>verification</category><category>codex</category><category>model-routing</category><category>reliability</category><category>cloudflare</category><category>kafka</category><category>postgres</category><category>scaling</category><category>performance</category><category>editor</category><category>productivity</category><category>tooling</category><category>drm</category><category>standards</category><category>epub</category><category>windows</category><category>authentication</category><category>user-experience</category><category>archival</category><category>web</category><category>finance</category><category>marketplace</category><category>auth</category><category>platform</category><category>storage</category><category>pricing</category><category>workflows</category><category>nitro</category><category>serverless</category><category>models</category><category>api</category><category>inference</category><category>collaboration</category><category>sharing</category><category>diabetes</category><category>pediatrics</category><category>sanofi</category><category>maternal-health</category><category>public-health</category><category>disability</category><category>caregivers</category><category>funding</category><category>ebola</category><category>who</category><category>drc</category><category>outbreak</category><category>crispr</category><category>gene-editing</category><category>obesity</category><category>cancer</category><category>drug-discovery</category><category>biotech</category><category>investment</category><category>abridge</category><category>drug-pricing</category><category>cms</category><category>history</category><category>nutrition</category><category>california</category><category>food</category><category>antibiotics</category><category>supply-chain</category><category>state-legislation</category><category>evidence</category><category>psychiatry</category><category>autism</category><category>stigma</category><category>medical-education</category><category>careers</category><category>demographics</category><category>hiring</category><category>industry</category><category>newsletter</category><category>venture-capital</category><category>musk</category><category>capital-markets</category><category>debt</category><category>corporate</category><category>growth</category><category>sports</category><category>regulation</category><category>betting</category><category>europe</category><category>brazil</category><category>agriculture</category><category>immigration</category><category>data</category><category>geopolitics</category><category>psychology</category><category>research</category><category>film</category><category>culture</category><category>cities</category><category>science</category><category>politics</category><category>links</category><category>roundup</category><category>philosophy</category><category>science-fiction</category><category>retail</category><category>service-sector</category><category>mexico</category><category>inflation</category><category>innovation</category><category>trade</category><category>strategy</category><category>bubbles</category><category>space</category><category>manufacturing</category><category>satellites</category><category>business-models</category></item></channel></rss>